ALFA Filings
Every announcement, straight from the exchange
Every Aspira Pathlab & Diagnostics promoter buying announcement on NSE and BSE, newest first, each with its own page.
Time
9 announcements with these filters
Promoter Jay Arvind Bhanushali acquired 1,424 equity shares of Aspira Pathlab & Diagnostics Ltd via market purchase. The transaction is valued at ₹0.02 Crore.
Promoter Jay Arvind Bhanushali acquired 1,424 shares of Aspira Pathlab & Diagnostics Ltd via the open market. This transaction increased the promoter's stake from 7.27% to 7.28%.
Promoter Jay Arvind Bhanushali acquired 1,387 equity shares of Aspira Pathlab & Diagnostics Ltd through market purchase, increasing their stake from 7.25% to 7.27%.
Promoter Jay Arvind Bhanushali acquired 1,387 shares of Aspira Pathlab & Diagnostics Ltd via an open-market transaction, increasing his stake by 0.02%.
Promoter Jay Arvind Bhanushali acquired 74 shares of Aspira Pathlab & Diagnostics Ltd via market purchase on September 10, 2026.
Promoter Jay Arvind Bhanushali acquired 957 shares of Aspira Pathlab & Diagnostics Ltd via market purchase for ₹0.01 Crore.
Jay Arvind Bhanushali (Promoter) acquired 623 equity shares of Aspira Pathlab & Diagnostics Ltd via open market, increasing his holding slightly.
Promoter Jay Arvind Bhanushali acquired 332 equity shares of Aspira Pathlab & Diagnostics Ltd via market purchase. This insider trading disclosure reports a value of ₹0.0029 Crore.
Jay Arvind Bhanushali, a promoter of Aspira Pathlab & Diagnostics Ltd, acquired 332 equity shares through the open market. This transaction increased the promoter's total holding from 7.23% to 7.24%.